HIRSCHMAN ORIN 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-10 4:59 pm Sale |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
HIRSCHMAN ORIN | 652,174 3.800% |
-139,644 (-17.64%) |
Filing |
| 2022-11-04 10:52 am Purchase |
2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO |
HIRSCHMAN ORIN | 791,818 6.100% |
791,818 (New Position) |
Filing |